"However, some say that Trump’s opposition to pot could actually help Canada’s industry.
U.S. companies who want to do research on marijuana’s medical applications face plenty of hurdles thanks to the drug’s status. That could leave a big opening for Canada.
“It creates a window of opportunity for us to do research without competition from America,” Bruce Linton, CEO of medical marijuana company Canopy Growth, told Global News."
I was really starting to worry that I was standing alone on an island, maybe with just a few companions, with this sentiment. Trump commits to keep marijuana illegal at the federal level, ok. Trump appoints leaders to the cabinet that support the same stance, ok.
Long term, ouch, that's going to put a strangle on the North American MJ market collectively. We all know the potential numbers for U.S. sales if recreational marijuana is permitted to flow through the streets, so no point in harping about that.
Short-term? Congrats, U.S. You're going to sit and stare while Canada leads the way in research and innovation. Those companies stand to profit and jump ahead of the crowd.
I really don't think much has changed, especially in the short term, now that Trump is about to sit in the Oval office. The best strategy still seems to be buying Canadian stocks and picking the companies that have the highest likelihood of making a run before drastic dilution is necessary or they become irrelevant in the market and close up shop.
News 
Market Data 
Discover 
